AI assistant
REPLIGEN CORP — Director's Dealing 2022
Feb 23, 2022
30826_dirs_2022-02-22_3c09eab9-44e3-43a9-a144-cb2c57695dec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-02-17
Reporting Person: Snodgres Jon (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-17 | Common Stock | A | 900 | $0.00 | Acquired | 30793 | Direct |
| 2022-02-17 | Common Stock | F | 332 | $182.42 | Disposed | 30461 | Direct |
Footnotes
F1: Represents shares issued pursuant to Performance Stock Unit ("PSU") award granted to the Issuer on January 4, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F2: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 2,000 shares, first reflected in a Form 4 filed on March 2, 2020.
F3: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.